Coherus Oncology, Inc. ( CHRS) - Stock Earnings
CHRS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
CHRS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -37.3 million USD | 12.7 million USD |
| 2026Q1 | -37.9 million USD | 12.3 million USD |
| 2026Q2 | -20.6 million USD | 14.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CHRS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -237.9 million USD | 257.2 million USD |
| 2024 | 28.5 million USD | 267.0 million USD |
| 2025 | -170.3 million USD | 42.2 million USD |
| 2026 Est. | — | — |
CHRS
Price: $1.07
52 week price:
Earnings Per Share: -1.24 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 749400
Ebitda: -55.8 millionMarket Capitalization: 173.0 million